Multimodal treatment for resectable esophageal cancer

General Thoracic and Cardiovascular Surgery

Volumn 59, Issue 7, 2011, Pages 461-466

  Miyata, Hiroshi ^a   Yamasaki, Makoto ^a   Kurokawa, Yukinori ^a   Takiguchi, Shuji ^a   Nakajima, Kiyokazu ^a   Fujiwara, Yoshiyuki ^a   Mori, Masaki ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Esophageal cancer; Neoadjuvant therapy Chemoradiation Chemoradiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; TS 1; UNCLASSIFIED DRUG; VINDESINE;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PANCREAS CANCER; POSTOPERATIVE CARE; POSTOPERATIVE CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; PREOPERATIVE TREATMENT; PROGRESSION FREE SURVIVAL; STOMACH CANCER; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; EVIDENCE-BASED MEDICINE; FLUOROURACIL; HUMANS; JAPAN; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; THERAPEUTICS; WESTERN WORLD;

EID: 79960305385     PISSN: 18636705     EISSN: 18636713     Source Type: Journal    
DOI: 10.1007/s11748-011-0780-6     Document Type: Article

References (46)

1. N. Altorki D. Skinner 2001 Should en bloc esophagectomy be the standard care for esophageal carcinoma? Ann Surg 234 581 587 11685019 10.1097/00000658-200111000-00001 1:STN:280:DC%2BD3MngvFyltQ%3D%3D (Pubitemid 33041759)
2. H. Akiyama M. Tsurumaru H. Udagawa Y. Kajiyama 1994 Radical lymph node dissection for cancer of the thoracic esophagus Ann Surg 220 364 372 8092902 10.1097/00000658-199409000-00012 1:STN:280:DyaK2cznvFyluw%3D%3D
3. S.M. Dresner S.M. Griffin 2000 Pattern of recurrence following radical oesophagectomy with two field lymphadenectomy Br J Surg 87 1426 1433 11044172 10.1046/j.1365-2168.2000.01541.x 1:STN:280:DC%2BD3crgtVGrsg%3D%3D
4. S. Nakagawa T. Kanda S. Kosugi M. Ohashi T. Suzuki K. Hatakeyama 2004 Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy J Am Coll Surg 198 205 211 14759776 10.1016/j.jamcollsurg.2003.10.005 (Pubitemid 38175235)
5. J.B. Hulscher J.W. van Sandick J.G. Tijssen H. Obertop J.J. van Lanschot 2000 The recurrence pattern of esophageal carcinoma after transhiatal resection J Am Coll Surg 191 143 148 10945357 10.1016/S1072-7515(00)00349-5 1:STN:280:DC%2BD3cvgvFKitg%3D%3D (Pubitemid 30622458)
6. M.S. Bhansali H. Fujita T. Kakegawa H. Yamana T. Ono S. Hikita, et al. 1997 Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus World J Surg 21 275 281 9015170 10.1007/s002689900228 1:STN:280: DyaK2s7mvV2jtg%3D%3D (Pubitemid 27100488)
7. G. Chen Z. Wang X.Y. Liu F.Y. Liu 2007 Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy World J Surg 31 1107 1104 17426905
8. C. Mariette J.M. Balon G. Piessen S. Fabre I. Van Seuningen J.P. Triboulet 2003 Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease Cancer (Phila) 97 1616 1623 10.1002/cncr.11228 (Pubitemid 36350704)
9. H. Kato H. Watanabe Y. Tachimori, et al. 1991 Evaluation of neck lymph node dissection for thoracic esophageal carcinoma Ann Thorac Surg 51 931 935 2039322 10.1016/0003-4975(91)91008-J 1:STN:280:DyaK3M3ksl2htA%3D%3D
10. K. Isono H. Sato K. Nakayama 1991 Results of a nationwide study on the three-field lymph node dissection of esophageal cancer Oncology 48 411 420 1745490 10.1159/000226971 1:STN:280:DyaK38%2FotVamtQ%3D%3D
11. T. Nishihira K. Hirayama S. Mori 1998 A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus Am J Surg 175 47 51 9445239 10.1016/S0002-9610(97)00227-4 1:STN:280:DyaK1c7gs1SitQ%3D%3D (Pubitemid 28047029)
12. H. Fujita S. Sueyoshi T. Tanaka T. Fujii U. Toh T. Mine, et al. 2003 Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy World J Surg 27 571 579 12715226 10.1007/s00268-003-6913-z (Pubitemid 36961129)
13. T.N. Walsh N. Noonan D. Hollywood A. Kelly N. Keeling T.P. Hennessy 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462 467 8672151 10.1056/NEJM199608153350702 1:STN:280: DyaK283psF2juw%3D%3D (Pubitemid 26269945)
14. J. Tepper M.J. Krasna D. Niedzwiecki D. Hollis C.E. Reed R. Goldberg, et al. 2008 Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 1086 1092 18309943 10.1200/JCO.2007.12.9593 1:CAS:528:DC%2BD1cXktVKitr0%3D
15. J.F. Bosset M. Gignoux J.P. Triboulet E. Tiret G. Mantion D. Elias, et al. 1997 Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 161 167 9219702 10.1056/NEJM199707173370304 1:STN:280:DyaK2szkslaitA%3D%3D (Pubitemid 27306287)
16. S. Urba M. Orringer A. Turrisi M. Iannettoni A. Forastiere M. Strawderman 1997 A randomized trial comparing surgery (S) to preoperative concomitant chemoradiation plus surgery in patients (pts) with respectable esophageal cancer (CA): updated analysis Proc Am Soc Clin Oncol 16 A983
17. K. Nyggard S. Hagen H.S. Hansen R. Hatlevoll R. Hultbom A. Jakobsen, et al. 1992 Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer World J Surg 16 1104 1110 10.1007/BF02067069 (Pubitemid 23065529)
18. E. Le Prise P.L. Etienne B. Meunier G. Maddem M. Ben Hassel D. Gedouin, et al. 1994 A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus Cancer (Phila) 73 1779 1784 10.1002/1097-0142(19940401)73:7<1779::AID- CNCR2820730702>3.0.CO;2-T (Pubitemid 24101950)
19. C. Apinop P. Puttisak N. Preecha 1994 A prospective study of combined therapy in esophageal cancer Hepatogastroenterology 41 391 393 7959579 1:STN:280:DyaK2M%2FkvVWisQ%3D%3D (Pubitemid 24273251)
20. B.H. Burmeister B.M. Smithers V. Gebski L. Fitzgerald R.J. Simes P. Devitt, et al. 2005 Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 659 668 16129366 10.1016/S1470-2045(05)70288-6 (Pubitemid 41222756)
21. L.M. Brown S.S. Devesa W.H. Chow 2008 Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age J Natl Cancer Inst 100 1184 1187 18695138 10.1093/jnci/djn211
22. R.S. Holmes T.L. Vaughan 2007 Epidemiology and pathogenesis of esophageal cancer Semin Radiat Oncol 17 2 9 17185192 10.1016/j.semradonc.2006.09.003 (Pubitemid 44918357)
23. N. Ando S. Ozawa Y. Kitagawa Y. Shinozawa M. Kitajima 2000 Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years Ann Surg 232 225 32 10903602 10.1097/00000658- 200008000-00013 1:STN:280:DC%2BD3cvgvVGltg%3D%3D (Pubitemid 30616724)
24. N. Ando T. Iizuka T. Kakegawa K. Isono H. Watanabe H. Ide, et al. 1997 A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study J Thorac Cardiovasc Surg 114 205 209 9270637 10.1016/S0022-5223(97)70146-6 1:STN:280:DyaK2svhs1KrtQ%3D%3D (Pubitemid 27364210)
25. N. Ando T. Iizuka H. Ide K. Ishida M. Shinoda T. Nishimaki, et al. 2003 Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204 J Clin Oncol 21 4592 4596 14673047 10.1200/JCO.2003.12.095 (Pubitemid 46594032)
26. H. Igaki H. Kato N. Ando M. Shinoda H. Shimizu T. Nakamura, et al. 2008 A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG9907) J Clin Oncol 26 suppl 215s
27. Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG Trial (JCOG 9906). Int J Radiat Oncol Biol Phys 2010; [Epub ahead of print].
28. J.A. Roth H.I. Pass M.M. Flanagan G.M. Graeber J.C. Rosenberg S. Steinberg 1988 Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus J Thorac Cardiovasc Surg 96 242 248 2456424 1:STN:280: DyaL1c3oslCktQ%3D%3D
29. P.M. Schlag 1992 Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group Arch Surg 127 1446 1450 1365692 1:STN:280:DyaK2M7jsVSktQ%3D%3D
30. K. Nygaard S. Hagen H.S. Hansen R. Hatlevoll R. Hultborn A. Jakobsen, et al. 1992 Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer World J Surg 16 1104 1109 1455880 10.1007/BF02067069 1:STN:280:DyaK3s%2FovVyhsg%3D%3D
31. T. Maipang P. Vasinanukorn C. Petpichetchian S. Chamroonkul A. Geater S. Chansawwaang, et al. 1994 Induction chemotherapy in the treatment of patients with carcinoma of the esophagus J Surg Oncol 56 191 197 7518020 10.1002/jso.2930560314 1:STN:280:DyaK2czgtV2ruw%3D%3D (Pubitemid 24226640)
32. S. Law M. Fok S. Chow K.M. Chu J. Wong 1997 Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial J Thorac Cardiovasc Surg 114 210 217 9270638 10.1016/S0022-5223(97)70147-8 1:STN:280:DyaK2svhs1Krug%3D%3D (Pubitemid 27364211)
33. D.P. Kelsen R. Ginsberg T.F. Pajak D.G. Sheahan L. Gunderson J. Mortimer, et al. 1998 Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 1979 1984 9869669 10.1056/NEJM199812313392704 1:STN:280:DyaK1M%2FnslCjsg%3D%3D (Pubitemid 29024130)
34. E. Ancona A. Ruol S. Santi S. Merigliano V.C. Sileni H. Koussis, et al. 2001 Only pathologic complete response to neoadjuvant chemotherapy improves signicantly the long-term survival of patients with respectable esophageal squamous cell carcinoma Cancer (Phila) 91 2165 2174 10.1002/1097-0142(20010601) 91:11<2165::AID-CNCR1245>3.0.CO;2-H 1:STN:280:DC%2BD3MzhvFeitA%3D%3D (Pubitemid 32476382)
35. Medical Research Council Oesophageal Cancer Working Group. 2002 Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial Lancet 359 1727 1733 10.1016/S0140-6736(02)08651-8 (Pubitemid 34607086)
36. V. Gebski B. Burmeister B.M. Smithers K. Foo J. Zalcberg J. Simes, et al. 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 226 234 17329193 10.1016/S1470-2045(07)70039-6 1:CAS:528:DC%2BD2sXisVCqs78%3D (Pubitemid 46291702)
37. M. Stahl M.K. Walz M. Stuschke N. Lehmann H.J. Meyer J. Riera-Knorrenschild, et al. 2009 Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 851 856 19139439 10.1200/JCO.2008.17.0506 1:CAS:528:DC%2BD1MXjs1Kntrw%3D
38. T. Iizuka T. Kakegawa H. Ide N. Ando H. Watanabe O. Tanaka, et al. 1992 Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial Jpn J Clin Oncol 22 172 176 1518165 1:STN:280:DyaK38zovFCluw%3D%3D
39. K. Hayashi N. Ando H. Watanabe H. Ide K. Nagai N. Aoyama, et al. 2001 Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407) Jpn J Clin Oncol 31 419 423 11689594 10.1093/jjco/hye090 1:STN:280:DC%2BD3MnksVOluw%3D%3D (Pubitemid 33039748)
40. H. Miyata A. Yoshioka M. Yamasaki Y. Nushijima S. Takiguchi Y. Fujiwara, et al. 2009 Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy Cancer (Phila) 115 3324 3334 10.1002/cncr.24390
41. E. Van Cutsem V.M. Moiseyenko S. Tjulandin A. Majlis M. Constenla C. Boni, et al. 2006 Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group J Clin Oncol 24 4991 4997 17075117 10.1200/JCO.2006.06.8429 (Pubitemid 46631401)
42. J.B. Vermorken E. Remenar C. van Herpen T. Gorlia R. Mesia M. Degardin, et al. 2007 Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 1695 1704 17960012 10.1056/NEJMoa071028 1:CAS:528:DC%2BD2sXht1ansLvP (Pubitemid 350005151)
43. M.R. Posner D.M. Hershock C.R. Blajman E. Mickiewicz E. Winquist V. Gorbounova, et al. 2007 Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 1705 1715 17960013 10.1056/NEJMoa070956 1:CAS:528:DC%2BD2sXht1ansLvI (Pubitemid 350005152)
44. J.A. Bonner P.M. Harari J. Giralt N. Azarnia D.M. Shin R.B. Cohen, et al. 2006 Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck N Engl J Med 354 567 568 16467544 10.1056/NEJMoa053422 1:CAS:528: DC%2BD28Xhtleksbs%3D (Pubitemid 43209104)
45. H. Safran M. Suntharalingam T. Dipetrillo T. Ng L.A. Doyle M. Krasna, et al. 2008 Cetuximab with concurrent chemoradiation for esophageal cancer: assessment of toxicity Int J Radiat Oncol Biol Phys 70 391 395 17980508 10.1016/j.ijrobp.2007.07.2325 1:CAS:528:DC%2BD1cXosVGnug%3D%3D
46. S. Lorenzen T. Schuster R. Porschen, et al. 2009 Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracial alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie Ann Oncol 20 1667 1673 19549707 10.1093/annonc/mdp069 1:STN:280:DC%2BD1MnjvFyisQ%3D%3D